Poor report compliance of insurance drug purchasing price list.

The government insurance drug price administration has encountered serious challenges. The actual purchasing price lists of insurance drugs were supposed to report to the government (KFMI) in compliance with the new pricing provision, Actual Purchasing Reimbursement Price System but up to Jan. 14 the report compliance has recorded merely at 25%.

The Korea Federation of Medical Insurance (KFM...